Literature DB >> 24900868

Facile Synthesis and Preliminary Structure-Activity Analysis of New Sulfonamides Against Trypanosoma brucei.

Adel A Rashad1, Amy J Jones2, Vicky M Avery2, Jonathan Baell3, Paul A Keller1.   

Abstract

The high throughput screening of a library of over 87,000 drug-like compounds against the African sleeping sickness parasite resulted in the discovery of hits with a wide range of molecular diversity. We report here the medicinal chemistry development of one such hit, a tetrahydroisoquinoline disulfonamide, with the synthesis and testing of 26 derivatives against the trypanosome subspecies. Activities in the 2-4 μM range were revealed with a selectivity index suitable for further development.

Entities:  

Keywords:  SAR; T. brucei; sulfonamides; tetrahydroquinoline

Year:  2014        PMID: 24900868      PMCID: PMC4027789          DOI: 10.1021/ml400487t

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  21 in total

Review 1.  Potential new drugs for human African trypanosomiasis: some progress at last.

Authors:  Michael P Barrett
Journal:  Curr Opin Infect Dis       Date:  2010-12       Impact factor: 4.915

Review 2.  Chemotherapy of trypanosomiases and leishmaniasis.

Authors:  Simon L Croft; Michael P Barrett; Julio A Urbina
Journal:  Trends Parasitol       Date:  2005-09-08

3.  Inhibition of rhodesain as a novel therapeutic modality for human African trypanosomiasis.

Authors:  Roberta Ettari; Lucia Tamborini; Ilenia C Angelo; Nicola Micale; Andrea Pinto; Carlo De Micheli; Paola Conti
Journal:  J Med Chem       Date:  2013-05-07       Impact factor: 7.446

Review 4.  The treatment of human African trypanosomiasis.

Authors:  J Pépin; F Milord
Journal:  Adv Parasitol       Date:  1994       Impact factor: 3.870

Review 5.  Human African trypanosomiasis, chemotherapy and CNS disease.

Authors:  Jean Rodgers
Journal:  J Neuroimmunol       Date:  2009-03-09       Impact factor: 3.478

6.  Stoking the drug target pipeline for human African trypanosomiasis.

Authors:  Margaret A Phillips
Journal:  Mol Microbiol       Date:  2012-08-28       Impact factor: 3.501

7.  Fexinidazole--a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness.

Authors:  Els Torreele; Bernadette Bourdin Trunz; David Tweats; Marcel Kaiser; Reto Brun; Guy Mazué; Michael A Bray; Bernard Pécoul
Journal:  PLoS Negl Trop Dis       Date:  2010-12-21

8.  SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis.

Authors:  Robert T Jacobs; Bakela Nare; Stephen A Wring; Matthew D Orr; Daitao Chen; Jessica M Sligar; Matthew X Jenks; Robert A Noe; Tana S Bowling; Luke T Mercer; Cindy Rewerts; Eric Gaukel; Jennifer Owens; Robin Parham; Ryan Randolph; Beth Beaudet; Cyrus J Bacchi; Nigel Yarlett; Jacob J Plattner; Yvonne Freund; Charles Ding; Tsutomu Akama; Y-K Zhang; Reto Brun; Marcel Kaiser; Ivan Scandale; Robert Don
Journal:  PLoS Negl Trop Dis       Date:  2011-06-28

9.  Identification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaign.

Authors:  Melissa L Sykes; Jonathan B Baell; Marcel Kaiser; Eric Chatelain; Sarah R Moawad; Danny Ganame; Jean-Robert Ioset; Vicky M Avery
Journal:  PLoS Negl Trop Dis       Date:  2012-11-29

10.  Towards the Atlas of human African trypanosomiasis.

Authors:  Giuliano Cecchi; Massimo Paone; José R Franco; Eric M Fèvre; Abdoulaye Diarra; José A Ruiz; Raffaele C Mattioli; Pere P Simarro
Journal:  Int J Health Geogr       Date:  2009-03-18       Impact factor: 3.918

View more
  3 in total

1.  Potent and Selective Inhibitors of 8-Oxoguanine DNA Glycosylase.

Authors:  Yu-Ki Tahara; Douglas Auld; Debin Ji; Andrew A Beharry; Anna M Kietrys; David L Wilson; Marta Jimenez; Daniel King; Zachary Nguyen; Eric T Kool
Journal:  J Am Chem Soc       Date:  2018-02-05       Impact factor: 15.419

2.  Investigation of thiazolyl-benzothiophenamides as potential agents for African sleeping sickness.

Authors:  Ronald W Brown; Ashraf M Abdel-Megeed; Paul A Keller; Amy J Jones; Melissa L Sykes; Marcel Kaiser; Jonathan B Baell; Vicky M Avery; Christopher J T Hyland
Journal:  RSC Med Chem       Date:  2020-09-23

3.  Synthesis and evaluation of novel 2,4-disubstituted arylthiazoles against T. brucei.

Authors:  Markos-Orestis Georgiadis; Violeta Kourbeli; Ioannis P Papanastasiou; Andrew Tsotinis; Martin C Taylor; John M Kelly
Journal:  RSC Med Chem       Date:  2019-12-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.